Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renascense Pharmaceuticals
Lakewood, New Jersey, United Statesrenpharm.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Renaissance Pharmaceuticals (primarily Renaissance Lakewood LLC / Renaissance Pharma, Inc.) is a US-based CDMO specializing in nasal sprays and sterile injectables, acquired by LTS in November 2025. It was previously backed by RoundTable Healthcare Partners (founded 2010, ~500 employees, $169M revenue). It focuses on contract manufacturing for pharma/biotech clients, not internal drug development. A separate UK entity 'Renaissance Pharma Ltd.' develops an anti-GD2 antibody (Hu14.18K322A) for neuroblastoma (Phase II complete), but no confirmed relation to the queried name or the US company. No exact match for 'Renascence Pharmaceuticals'; closest is 'Renaissance Pharmaceuticals' variants.
- Industry
- Contract Manufacturing Organization
02
Partnerships
Tiziana Life SciencesLTS Lohmann Therapie-Systeme AG
Beyond the preview
Go deeper on Renascense Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Renascense Pharmaceuticals.